Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Dermatology Market Research

Atopic Dermatitis Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027

Best Price Guarantee Length Publisher Published Date SKU
from $3,950 107 Pages GlobalData November, 2022 GBDT17548646
Best Price Guarantee
Price from $3,950
Length 107 Pages
Publisher GlobalData
Published Date November, 2022
SKU GBDT17548646

Atopic Dermatitis Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027

Summary

The Global Atopic Dermatitis market size was valued at US$6.8 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 10.3% during 2022-2027. The Global Atopic Dermatitis market report provides an executive-level overview of the atopic dermatits market worldwide today, with detailed forecasts of key indicators up to 2027.

This market intelligence report offers a thorough, forward-looking analysis of the global atopic dermatitismarket, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.

The Atopic Dermatitis market size was valued at US$6.8 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 10.3% during the forecast period (2022-2027). The market is driven by the rising prevalence of atopic dermatitis, and the rising demand for bioligcs in treating AD.

Scope

  • Overview of atopic dermatitis market including industry trends, funding & deals, pipeline analysis, regulatory details, and product & company profile
  • Atopic Dermatitis market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the product, technology, application and geographic segments.
  • Atopic Dermatitis market outlook: analysis as well as forecasts of revenue opportunities from the drug class segments.
  • Atopic Dermatitis market outlook: analysis as well as forecasts of revenue opportunities from the route of administrtaion segment.
  • The competitive landscape: an examination of the positioning of leading players in Atopic Dermatitis market.
Reasons to Buy
  • This market intelligence report offers a thorough, forward-looking analysis of the global Atopic Dermatitis market and key opportunities in a concise format to help executives build proactive and profitable growth strategies.
  • Accompanying GlobalData’s Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in Atopic Dermatitis markets.
  • The report also highlights key component, end-user, and technology segments.
  • With different charts and tables, the report is designed for an executive-level audience, boasting presentation quality.
  • The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in Atopic Dermatitis market.


  • Executive Summary
    • Atopic Dermatitis Market Snapshot
      • Table Fig.1 Market Snapshot ($Mn)
    • Atopic Dermatitis Market- Key Findings
      • Table Fig.2 Key Segment Performance Snapshot
      • Table Key Trends Overview
  • Research Scope and Segmentation
    • Table Research Scope And Segmentation
  • Technology Briefing
    • Disease Overview
      • ETIOLOGY AND PATHOPHYSIOLOGY
        • Table Fig. 4 Major Drug Targets for AD Treatment
        • Table Fig. 5 Major Drug Targets for AD Treatment
      • CLASSIFICATION OR STAGING SYSTEMS
    • Epidemiology
      • DISEASE BACKGROUND
      • RISK FACTORS AND COMORBIDITIES
        • Table Risk Factors and Comorbidities for AD
      • GLOBAL AND HISTORICAL TRENDS
      • GLOBAL DATA EPIDEMIOLOGICAL FORECAST METHODOLOGY
      • EPIDEMIOLOGICAL FORECAST FOR DISEASE AD
        • Table Fig.3 7MM, Age-Specific 12-Month Diagnosed Prevalent Cases of AD, N, Men and Women, 2020
        • Table Fig.4 7MM, Sex-Specific 12-Month Diagnosed Prevalent Cases of AD, N, All Ages, 2020
        • Table Fig.5 7MM, 12-Month Diagnosed Prevalent Cases by Severity, Men and Women, N, All Ages, 2020
      • DISCUSSION
  • Disease Management
    • Diagnosis and Treatment Overview
      • Table Treatment Guidelines for AD.
      • Table Fig.6 Flowchart of the Diagnosis and Management of AD Patient presents with skin manifestations consistent with
    • KOL Insights on Disease Management
      • LONG TERM DISEASE CONTROL (EFFICACY)
      • TREATMENT APPROACH
  • Competitive Assessment
    • Overview
  • Unmet Needs and Opportunity Assessment
    • Overview
    • Lack of Therapeutic Options for Chronic Hand Eczema
    • Better Long-Term Disease Control and Management
    • More Tolerable Topical Treatment Options
    • Improved Patient Treatment Compliance
    • Increased Diversity in AD Clinical Trial Recruitment
  • R&D Strategies
    • Overview
      • Rise of the JAK Inhibitors
      • RISE OF INTERLEUKIN-INHIBITING BIOLOGICS
      • TARGETING NEW SIGNALING PATHWAYS/NOVEL TARGETS
    • Clinical Trials Design
      • Clinical Trial Design in AD
      • Clinical Trial Design in CHE
  • Pipeline Assessment
    • Overview
      • Table Fig.7 Overview of the Development Pipeline in AD
    • Promising Drugs in Clinical Development
      • Mild to Moderate Agents
      • Moderate-to-Severe Agents
  • Pipeline Valuation Analysis
    • Overview
    • Competitive Assessment
      • Systemic Agents
        • Table Fig.8 Competitive Assessment of Marketed and Pipeline Systemic Drugs Benchmarked Against the SOC, Dupixent
      • Topical Agents
        • Table Fig.9 Competitive Assessment of Marketed and Pipeline Systemic Drugs Benchmarked Against the SOC, Dupixent
  • Current and Future Players
    • Overview
    • Deal-Making Trends
  • Atopic Dermatitis Industry Trends Analysis
    • Atopic Dermatitis Market Structure - PORTER’s Analysis
      • Table Fig. 10 Atopic Dermatitis Global Atopic Dermatitis PORTER’s Five Force Analysis
  • Global Atopic Dermatitis Revenue Opportunity
    • Global Atopic Dermatitis Market
      • Table Fig.10 Global Atopic Dermatitis Market - Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • Table Atopic Dermatitis Market
    • COVID-19 Impact
  • Atopic Dermatitis Drug Class Outlook
    • Atopic Dermatitis - Drug Class Deep Dive
      • Table Fig.11 Atopic Dermatitis by Drug Class- Market Overview ($Mn)
      • Table Fig.12 Atopic Dermatitis by Drug Class Share - 2021 & 2027 (%)
      • Table Atopic Dermatitis by Drug Class, 2020-2027 ($Mn)
      • CORTICOSTEROIDS
        • Table Fig.13 Corticosteroids Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • CALCINEURIN INHIBITORS
        • Table Fig.14 Calcineurin Inhibitors Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • PDE4 INHIBITORS
        • Table Fig.15 PDE4 Inhibitors Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • BIOLOGICS
        • Table Fig.16 Biologics Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • OTHER DRUG CLASSES
        • Table Fig.17 Other Drug Classes Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
  • Atopic Dermatitis Route of Administration Outlook
    • Atopic Dermatitis - Route of Administration Deep Dive
      • Table Fig.18 Atopic Dermatitis by Route of Administration- Market Overview ($Mn)
      • Table Fig.19 Atopic Dermatitis by Route of Administration Share - 2021 & 2027 (%)
      • Table Atopic Dermatitis by Route of Administration, 2020-2027 ($Mn)
      • INJECTABLE
        • Table Fig.20 Injectable Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • ORAL
        • Table Fig.21 Oral Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • TOPICAL
        • Table Fig.22 Topical Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
  • Atopic Dermatitis Regional Outlook
    • Atopic Dermatitis - Regional Deep Dive
      • Table Fig.23 Global Atopic Dermatitis by Region- Market Overview ($Mn)
      • Table Fig.24 Global Atopic Dermatitis by Region Share - 2021 & 2027 (%)
      • Table Atopic Dermatitis by Region, 2020-2027 ($Mn)
      • NORTH AMERICA
        • Table Fig.25 North America Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
        • Table North America Atopic Dermatitis by Country, 2020-2027 ($Mn)
      • EUROPE
        • Table Fig.26 Europe Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
        • Table Europe Atopic Dermatitis by Country, 2020-2027 ($Mn)
      • ASIA-PACIFIC
        • Table Fig.27 Asia-Pacific Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
        • Table Asia-Pacific Atopic Dermatitis by Country, 2020-2027 ($Mn)
      • ROW
        • Table Fig.28 ROW Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
  • Trends, Drivers, and Challenges
    • Atopic Dermatitis - Market Trends
      • CONSTANT COMPETITION TO LAUNCH NEW DRUGS
    • Atopic Dermatitis - Market Drivers
      • RISING PREVALENCE OF ATOPIC DERMATITIS
      • THE RISING DEMAND FOR BIOLOGICS IN ATOPIC DERMATITIS
    • Atopic Dermatitis - Market Challenges
      • INCREASE OF HYPERSENSITIVE REACTION LEADING TO PRODUCT RECALLS
      • HIGH TREATMENT COST, AND LACK OF REIMBURSEMENT GUIDELINES IN DEVELOPING COUNTRIES.
  • Global Atopic Dermatitis Competitive Landscape
    • Atopic Dermatitis Vendor Snapshot
      • COMPANY SNAPSHOT: SANOFI
      • COMPANY SNAPSHOT: PFIZER INC.
      • COMPANY SNAPSHOT: ABBVIE INC.
      • COMPANY SNAPSHOT: INCYTE CORPORATION
      • COMPANY SNAPSHOT: REGENERON PHARMACEUTICALS INC.
      • COMPANY SNAPSHOT: LEOPHARMA INC
      • COMPANY SNAPSHOT: OTSUKA PHARMACEUTICAL CO., LTD.
      • COMPANY SNAPSHOT: GALDERMA LABORATORIES, L.P.
      • COMPANY SNAPSHOT: DERMIRA, INC. (ELI LILLY AND COMPANY)
  • Appendix
    • Abbreviations
    • Methodology
    • Key Themes Impacting the Pharmaceutical Industry
    • About US
  • Contact Us

$3,950
$5,950
$7,950

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings